Improved Recovery of Walking in Acquired Muscle Weakness
Recruiting
N/A
Interventional Study
Critical Illness Myopathy
Critical Illness Polyneuropathy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 72 (estimated)
- Sponsor
- Fondazione Don Carlo Gnocchi ETS · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of Re-Walk-Easy is to evaluate the effects of rehabilitation based on electrical stimulation on the motor performance of critically ill patients. The study will also investigate the pathophysiology of the two forms-the myopathic-predominant and the polyneuropathic-predominant variants-by examining the longitudinal progression of CIP and CIM and determining which form benefits more from ele…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Critical Illness Patient Inclusion Criteria:
* clinical diagnosis of tetra/paraparesis of peripheral origin as disclosed by ENG/EMG examination;
* be independent before the episode of critical illness
Critical Illness Patient Exclusion Criteria:
* history of previous comorbidity for ICU-AW;
* pre…
Contacts